Summary of The Trip Treatment

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

The Trip Treatment summary

Editorial Rating

8

Qualities

  • Controversial
  • Scientific
  • Engaging

Recommendation

Journalist Michael Pollan explains the fascinating history of medical research into psychedelics and captures the sense of wonder among researchers and patients experimenting with them today. It’s hard not to be amazed by Pollan’s accounts of mystical, life-changing experiences – especially among patients facing death. The findings from patients’ brain scans also make intriguing reading. getAbstract recommends this article to anyone who wants to know exactly how the brain creates mystical experiences, either drug-induced or otherwise.

About the Author

Michael Pollan teaches journalism at the University of California, Berkeley.

Summary

In 1953, the first government-funded medical research into psychedelics took place in the United States. Over the next 20 years, researchers used lysergic acid diethylamide (LSD) in more than 1,700 patients, including addicts, those with terminal cancer and the mentally ill. The findings were encouraging, but the studies were often poorly conceived or executed. When then US president Richard Nixon outlawed psychedelics in 1970, the studies ceased and the field of psychiatry moved on.

In 2006, respected drug addiction researcher Roland Griffiths...


Comment on this summary

More on this topic

Immune System, Unleashed by Cancer Therapies, Can Attack Organs
9
Olympic Icon Flo Jo Raced to the Top and Took Us with Her
8
Biopharma Applies New Service and Support Models amid COVID-19
8
When Patients Become Innovators
8
COVID-19 Ushers In Decades of Change for Nursing Profession
9
4 Factors That Help Leaders Lead Successful Change
9

Related Channels